ABSTRACT
INTRODUCTION
Nuchal translucency (NT) is the normal fluid filled subcutaneous space measured at the back of the fetal neck measured in the late first trimester and early second trimester. In fetuses with genetic defects, cardiac anomalies and chromosomal abnormalities we can observe an increased nuchal translucency. Nuchal translucency screening can detect approximately 80% of fetuses with Down syndrome and other major aneuploidies with a rate of 5% of false positive results, but the merger of the NT screening with β-hCG and PAPP-A testing increases the detection rate to 90% [1] . There are new studies that show that the rate of detection can be increased to 95% examining the length of the nasal bone, the tricuspid and ductus venosus blood flow [2] .Studies have shown that a NT of 3 mm in late first trimester carries a 4-fold risk for fetal trisomies, and a NT greater than 3 mm a 29-fold risk, even if the fetus has a normal karyotype, furthermore a NT of 4 mm or more is associated strongly with poor pregnancy outcomes [3] . The ultrasonographic evaluation of the NT was first described in 1985 by Benacerraf et al [3] .
Nuchal fold thickness (NFT, measured between 16 and 24 weeks of gestation) has been accepted as markers for Down syndrome, with a normal value of less than 6 mm in multiple studies [4] - [6] .
The protocol for the NFT assessment is strictly regulated, because the overestimation of the NFT can lead to an increase in invasive diagnostic tools like amniocentesis and chorionic villus sampling. The measurement should be made at the transcerebellar section level, having cavum septum pellucidum, the cerebral peduncles, the cerebellar peduncles and cisterna magna as ultrasonographic landmarks [4] , [7] . 
MATERIALS AND METHODS
We present the case of a fetus with a NT of 49 mm detected at the first trimester ultrasound morphologic exam. The Kryptor test revealed a 1:35 risk for Trisomy 13 and 1:721 for Trisomy 18.
RESULTS
We report the case of an investigated pregnancy with a NT of 49 mm detected at the first trimester ultrasound exam, with a risk of 1:35 for Trisomy 13 and 1:721 for Trisomy 18 calculated at the Kryptor test. A chorionic villus sampling was recommended and performed with a result of 46XY normal karyotype. The second trimester ultrasound morphologic exam showed a normal NFT of 5.59 mm, with a normal development, no major cardiac anomalies visible. The pregnancy was supervised by an OBGYN specialist, no maternal pathology present.
DISCUSSIONS
Although the implementation of the nuchal translucency (NT) evaluation in 1992 by Nicolaides et al was a major medical advance in the screening for chromosomal aneuploidies in the first trimester, other pathological conditions besides chromosomal aneuploidies are also linked with increased NT, but there are also the cases of normal fetuses with increased NT [8] .
A study on a group of patients from Iasi, Romania concluded that even though it's a common practice to indicate an amniocentesis or a chorionic villus sampling in fetuses with an increased NT the majority of cases with increased NT in the study did not involve the presence of an aneuploidy, furthermore the pregnancy result in a positive outcome if no other anomaly is present, but the need for larger multicenter studies is pressing [8] .
Another study published in 2015 concluded that there was no link between first trimester nuchal translucency measurements and complications that could develop in pregnancy [9] .
Multiple studies concluded that negative pregnancy outcome increased with increasing NT, even if it is a minimal increase, even in fetuses with normal karyotype, but the overall prognosis is good if the second trimester ultrasound screening is negative for fetal abnormalities, the most frequent one detected in fetuses with increased NT being cardiac defects [10] , [11] .
CONCLUSIONS
The particularity of this case is represented by the increased nuchal translucency as well as an increased risk for trisomy 13 and 18 in a normal karyotype fetus that had a normal development in the second and third trimester with no pregnancy complications arising.
